An AllTrials project

NCT02629094: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)

This trial has reported on time, in line with the regulations.

Full data

Full entry on ClinicalTrials.gov NCT02629094
Title Cardiometabolic Effects of Eplerenone in HIV Infection
Results Status Reported
ACT or pACT? This is what FDAAA officially calls a "probable Applicable Clinical Trial"
Start date Dec. 2, 2015
Completion date Sept. 11, 2017
Required reporting date Sept. 11, 2018, midnight
Actual reporting date May 7, 2018
Date last checked at ClinicalTrials.gov March 28, 2025
Days late None